摘要
TO THE EDITOR We read the study by Medeiros-Filho et al with much interest. The study shed light on early HCV RNA kinetics in conjunction with liver cirrhosis, different genotypes （gen-1 vs gen-3） of HCV and sustained viral response （SVR） rates. In particular, Medeiros-Filho et al showed that the HCV RNA first phase decline, under interferon-or （IFN） and ribavirin therapy,
TO THE EDITORWe read the study by Medeiros-Filho et al[1] with much interest. The study shed light on early HCV RNA kinetics in conjunction with liver cirrhosis, different genotypes (gen-1 vs gen-3) of HCV and sustained
基金
NIH grants RR06555 and P20-RR18754
the U.S.Department of Energy under contract DE-AC52-06NA25396
